The industrial application requirement for biotech inventions in light of recent EPO & UK case law: A plausible "hunting license"?

Activity: Talk or presentation types › Lecture and oral contribution

Description

This presentation will discuss the most recent developments relating to the “industrial application” requirement with a special emphasis on gene and protein-related inventions in Europe. In addition to providing a brief overview of the applicable legislative framework, this presentation will address relevant EPO practice and the UK Supreme Court’s seminal decision in HGS v Eli Lilly.
Period12 Aug 2013
Event titlePharmaceutical Law & Policy- Hot topics shaping the future of the pharma industry: Copenhagen Summer University 2013
Event typeCourse
LocationCopenhagen, DenmarkShow on map

Documents & Links

Related content